These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 22736575)

  • 41. Working memory function in post-traumatic stress disorder: an event-related potential study.
    Veltmeyer MD; Clark CR; McFarlane AC; Moores KA; Bryant RA; Gordon E
    Clin Neurophysiol; 2009 Jun; 120(6):1096-106. PubMed ID: 19442579
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cannabis therapy.
    Müller-Vahl K; Grotenhermen F
    Dtsch Arztebl Int; 2013 Mar; 110(9):144. PubMed ID: 23533555
    [No Abstract]   [Full Text] [Related]  

  • 43. Cannabis therapy.
    Kowalski JT
    Dtsch Arztebl Int; 2013 Mar; 110(9):144. PubMed ID: 23533556
    [No Abstract]   [Full Text] [Related]  

  • 44. Translation of animal endocannabinoid models of PTSD mechanisms to humans: Where to next?
    Ney LJ; Crombie KM; Mayo LM; Felmingham KL; Bowser T; Matthews A
    Neurosci Biobehav Rev; 2022 Jan; 132():76-91. PubMed ID: 34838529
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The potential of inhibitors of endocannabinoid metabolism as anxiolytic and antidepressive drugs--A practical view.
    Fowler CJ
    Eur Neuropsychopharmacol; 2015 Jun; 25(6):749-62. PubMed ID: 25791296
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glucocorticoid-induced reduction of traumatic memories: implications for the treatment of PTSD.
    de Quervain DJ
    Prog Brain Res; 2008; 167():239-47. PubMed ID: 18037019
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Functional role of the endocannabinoid system in emotional homeostasis].
    Marco EM; Viveros MP
    Rev Neurol; 2009 Jan 1-15; 48(1):20-6. PubMed ID: 19145562
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids.
    Hanus LO
    Med Res Rev; 2009 Mar; 29(2):213-71. PubMed ID: 18777572
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….
    Baron EP
    Headache; 2015 Jun; 55(6):885-916. PubMed ID: 26015168
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Toward rational pharmacotherapy for posttraumatic stress disorder: an interim report.
    Friedman MJ
    Am J Psychiatry; 1988 Mar; 145(3):281-5. PubMed ID: 2894174
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Evaluation of Post-traumatic Stress Disorder: validation of a measure, the PCLS].
    Yao SN; Cottraux J; Note I; De Mey-Guillard C; Mollard E; Ventureyra V
    Encephale; 2003; 29(3 Pt 1):232-8. PubMed ID: 12876547
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dopamine, endocannabinoids and their interaction in fear extinction and negative affect in PTSD.
    Ney LJ; Akhurst J; Bruno R; Laing PAF; Matthews A; Felmingham KL
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 105():110118. PubMed ID: 32991952
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Effectiveness of Cannabinoids in the Treatment of Posttraumatic Stress Disorder (PTSD): A Systematic Review.
    Hindocha C; Cousijn J; Rall M; Bloomfield MAP
    J Dual Diagn; 2020; 16(1):120-139. PubMed ID: 31479625
    [No Abstract]   [Full Text] [Related]  

  • 54. Advances in the pharmacotherapeutic management of post-traumatic stress disorder.
    Akhtar A; Pilkhwal Sah S
    Expert Opin Pharmacother; 2021 Oct; 22(14):1919-1930. PubMed ID: 34124975
    [No Abstract]   [Full Text] [Related]  

  • 55. Drug utilization trends in patients with posttraumatic stress disorder in a postconflict setting: consistency with clinical practice guidelines.
    Letica-Crepulja M; Korkut N; Grahovac T; Curac J; Lehpamer K; Franciskovic T
    J Clin Psychiatry; 2015 Oct; 76(10):e1271-6. PubMed ID: 26528649
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transmitter systems involved in neural plasticity underlying increased anxiety and defense--implications for understanding anxiety following traumatic stress.
    Adamec R
    Neurosci Biobehav Rev; 1997 Nov; 21(6):755-65. PubMed ID: 9415900
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacotherapeutic treatment of nightmares and insomnia in posttraumatic stress disorder: an overview of the literature.
    van Liempt S; Vermetten E; Geuze E; Westenberg H
    Ann N Y Acad Sci; 2006 Jul; 1071():502-7. PubMed ID: 16891608
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacological treatment to prevent and treat post-traumatic stress disorder.
    Bisson JI
    Torture; 2008; 18(2):104-6. PubMed ID: 19289887
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prescribing trends in veterans with posttraumatic stress disorder.
    Bernardy NC; Lund BC; Alexander B; Friedman MJ
    J Clin Psychiatry; 2012 Mar; 73(3):297-303. PubMed ID: 22490256
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential effectiveness of tianeptine, clonidine and amitriptyline in blocking traumatic memory expression, anxiety and hypertension in an animal model of PTSD.
    Zoladz PR; Fleshner M; Diamond DM
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():1-16. PubMed ID: 23318688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.